comparemela.com
Home
Live Updates
Idiopathic Hypersomnia Severity Scale - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Idiopathic hypersomnia severity scale - Page 1 : comparemela.com
Low-sodium Oxybate Improves Idiopathic Hypersomnia Symptoms, Even Sleep Inertia
Low-sodium oxybate treatment may improve sleep inertia via changes in VAS-SI scores, for patients with idiopathic hypersomnia.
United states
American academy of neurology
Idiopathic hypersomnia severity scale
Epworth sleepiness scale
Patient global impression
Zevra Highlights Plans to Advance IH, Narcolepsy Drug Candidate
Zevra reported progress in 2023, including results from a phase 2 study for idiopathic hypersomnia and plans to expand into narcolepsy.
Neilf mcfarlane
Drug administration
Zevra therapeutics inc
Investigational new drug
Therapeutics inc
Epworth sleepiness
Idiopathic hypersomnia severity scale
Sleep inertia visual analog scale
Brain fog
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms
A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.
United states
Christopher drake
Henry ford health christopher drake
American academy of sleep medicine
Drug administration
Us drug enforcement agency
Henry ford health
Zevra therapeutics
American academy
Orphan drug designation
Enforcement agency
Epworth sleepiness scale
Idiopathic hypersomnia severity scale
Sleep inertia visual analog scale
Epworth sleepiness
Brain fog severity scale
Zevra Reports Positive Phase 2 Results for IH Drug Candidate
Zevra Therapeutics announced positive topline results from its phase 2 clinical trial evaluating KP1077 for idiopathic hypersomnia (IH).
Putilich dreamstime
Christopher drake
Neil mcfarlane
Drug administration
Zevra therapeutics
Epworth sleepiness scale
Idiopathic hypersomnia severity scale
Sleep inertia visual analog scale
Brain fog
Zevra Therapeutics Announces Top-Line Data from the Phase 2
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study .
United states
Christopher drake
Neil mcfarlane
Nichol ochsner
Ignacio guerrero ros
Adannag alexander
Zevra therapeutics inc
Us drug enforcement agency
Drug administration
Exchange commission
Epworth sleepiness scale
Idiopathic hypersomnia severity scale
Sleep inertia visual analog scale
Principal investigator
Chief executive officer
Brain fog
vimarsana © 2020. All Rights Reserved.